Regulation of T-cell function and autoimmune inflammation by deubiquitinase CYLD
去泛素酶 CYLD 对 T 细胞功能和自身免疫炎症的调节
基本信息
- 批准号:8289618
- 负责人:
- 金额:$ 48.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-07-01 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:Adoptive TransferAnimal ModelAntigensAttenuatedAutoimmune ProcessAutoimmunityBiochemicalBone MarrowCD4 Positive T LymphocytesCell physiologyCellsChronicColitisComplicationCoupledDataDeubiquitinationDevelopmentDiseaseEnteralEnvironmental Risk FactorEventExperimental Autoimmune EncephalomyelitisFundingGene Expression RegulationGeneticHomeostasisHumanITGAM geneImmune System DiseasesImmune responseInfectionInflammationInflammatoryInflammatory Bowel DiseasesInflammatory disease of the intestineIntestinesKnock-outKnockout MiceKnowledgeLaboratoriesLeadLinkLymphocyteLysineMediatingMicrobeMolecularMusNF-kappa BNormal tissue morphologyOsteoclastsOsteopeniaOsteoporosisPatientsPhosphotransferasesPopulationProductionPublishingRag1 MouseRegulationRegulatory T-LymphocyteResearch Project GrantsRoleSeminalSignal TransductionSpleenT cell differentiationT cell responseT memory cellT-Cell ActivationT-LymphocyteTh1 CellsUbiquitinUbiquitinationWorkattenuationbasebonebone losscytokinedesignexperiencemacrophagemicrobialosteoclastogenesispreventpublic health relevanceresponsetherapy designtranscription factorubiquitin ligaseubiquitin-protein ligase
项目摘要
DESCRIPTION (provided by applicant): T cells effectively respond to foreign antigens but are tolerant to self-tissues and normal enteric flora. Inappropriate activation or differentiation of T cells can lead to severe immunological disorders, including autoimmunity and inflammation. Thus, a better understanding of the molecular mechanisms regulating T-cell activation and tolerance is important for rational design of therapies for immunological diseases. The overall objective of this application is to understand the molecular and cellular mechanisms by which a newly identified deubiquitinase (DUB), CYLD, regulates T-cell function and autoimmune inflammation. During the current funding period, we have made seminal findings that establish CYLD as a pivotal regulator of T-cell activation and autoimmune inflammation. CYLD-deficient T cells are hyper-responsive to TCR stimulation, and the CYLD knockout (CYLD-/-) mice spontaneously develop intestinal inflammation with major features of human inflammatory bowel disease (IBD). The CYLD-/- mice also experience severe bone loss, which is known as a major extra-intestinal complication of IBD and animal model of colitis. Moreover, our preliminary studies reveal that loss of CYLD renders mice hypersensitive to the induction of experimental autoimmune encephalomyelitis (EAE). Thus, CYLD is a master regulator of T-cell function and autoimmune inflammatory diseases. The studies proposed in this continuation application are based on strong preliminary and published data from our laboratory. In particular, we have shown that loss of CYLD in T cells causes constitutive activation of NF-kB, a transcription factor mediating T-cell activation and survival and being involved in many inflammatory disorders. The CYLD-/- T cells also display marked attenuation of the costimulatory molecule ICOS, which is crucial for the induction of T-cell tolerance and regulation of T-cell differentiation. Consistent with these molecular studies, we have found that the CYLD-/- T cells appear to be defective in tolerance to enteric microbes, since their adoptive transfer into lymphocyte-deficient Rag1-/- mice induces severe colitis. Furthermore, the CYLD-/- mice produce aberrantly high levels of inflammatory Th17 and Th1 cells, coupled with heightened EAE response. We have obtained preliminary evidence that CYLD regulates macrophage response to TLR-stimulated expression of a specific subset of cytokines known to regulate Th1 and Th17 differentiation. Based on these findings, we hypothesize that CYLD regulates key signaling events involved in T-cell activation and differentiation as well as tolerance induction. We will perform three specific aims to accomplish our overall objective. (1) Examine the molecular mechanism and functional significance of CYLD-mediated NF-kB regulation in T cells. (2) Characterize the molecular and cellular mechanisms by which CYLD regulate T-cell tolerance and inflammatory T-cell differentiation. (3) Examine the immunological and osteoclast-intrinsic mechanisms by which CYLD regulates bone erosion.
PUBLIC HEALTH RELEVANCE: T cells are vital for immune responses against microbial infections. However, deregulated T cell activation, due to genetic or environmental factors, can lead to severe immunological disorders, including autoimmunity and chronic inflammation. The focus of this research project is to understand how a deubiquitinase, CYLD, regulates T-cell activation and tolerance, thereby preventing the development of autoimmunity and inflammation. This knowledge is important for rational design of effective immunological therapies.
描述(由申请人提供):T 细胞有效对外源抗原作出反应,但对自身组织和正常肠道菌群具有耐受性。 T 细胞的不当激活或分化可导致严重的免疫紊乱,包括自身免疫和炎症。因此,更好地了解调节 T 细胞激活和耐受的分子机制对于合理设计免疫疾病疗法非常重要。该应用的总体目标是了解新鉴定的去泛素酶 (DUB) CYLD 调节 T 细胞功能和自身免疫炎症的分子和细胞机制。在当前资助期间,我们取得了开创性的发现,将 CYLD 确立为 T 细胞激活和自身免疫炎症的关键调节因子。 CYLD 缺陷的 T 细胞对 TCR 刺激反应过度,CYLD 敲除 (CYLD-/-) 小鼠会自发产生肠道炎症,其主要特征是人类炎症性肠病 (IBD)。 CYLD-/-小鼠还经历严重的骨质流失,这被认为是IBD和结肠炎动物模型的主要肠外并发症。此外,我们的初步研究表明,CYLD 的缺失使小鼠对实验性自身免疫性脑脊髓炎 (EAE) 的诱导过敏。因此,CYLD 是 T 细胞功能和自身免疫炎症性疾病的主要调节因子。 本延续申请中提出的研究基于我们实验室强有力的初步和已发表的数据。特别是,我们已经证明,T 细胞中 CYLD 的丢失会导致 NF-kB 的组成性激活,NF-kB 是介导 T 细胞激活和存活的转录因子,并参与许多炎症性疾病。 CYLD-/- T细胞还表现出共刺激分子ICOS的显着减弱,这对于诱导T细胞耐受和调节T细胞分化至关重要。与这些分子研究一致,我们发现 CYLD-/- T 细胞似乎对肠道微生物的耐受性有缺陷,因为它们过继转移到淋巴细胞缺陷的 Rag1-/- 小鼠中会诱发严重的结肠炎。此外,CYLD-/- 小鼠产生异常高水平的炎症 Th17 和 Th1 细胞,同时 EAE 反应增强。我们已经获得了初步证据,表明 CYLD 调节巨噬细胞对 TLR 刺激的已知调节 Th1 和 Th17 分化的特定细胞因子子集表达的反应。基于这些发现,我们假设 CYLD 调节涉及 T 细胞激活和分化以及耐受诱导的关键信号转导事件。我们将实现三个具体目标来实现我们的总体目标。 (1) 研究CYLD介导的T细胞NF-kB调节的分子机制和功能意义。 (2) 表征CYLD调节T细胞耐受和炎症T细胞分化的分子和细胞机制。 (3) 检查CYLD调节骨侵蚀的免疫学和破骨细胞内在机制。
公共卫生相关性:T 细胞对于针对微生物感染的免疫反应至关重要。然而,由于遗传或环境因素,T 细胞激活失调可能导致严重的免疫疾病,包括自身免疫和慢性炎症。该研究项目的重点是了解去泛素酶 CYLD 如何调节 T 细胞激活和耐受,从而防止自身免疫和炎症的发展。这些知识对于合理设计有效的免疫疗法非常重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shao-Cong Sun其他文献
Shao-Cong Sun的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shao-Cong Sun', 18)}}的其他基金
Molecular mechanisms underlying immunosuppression and inflammation caused by SARS-CoV2 proteins
SARS-CoV2蛋白引起免疫抑制和炎症的分子机制
- 批准号:
10163402 - 财政年份:2020
- 资助金额:
$ 48.88万 - 项目类别:
Molecular mechanisms regulating TLR signaling and inflammation
调节 TLR 信号传导和炎症的分子机制
- 批准号:
10265710 - 财政年份:2020
- 资助金额:
$ 48.88万 - 项目类别:
Signaling functions of Peli family of E3 ubiquitin ligases
E3 泛素连接酶 Peli 家族的信号传导功能
- 批准号:
8660625 - 财政年份:2013
- 资助金额:
$ 48.88万 - 项目类别:
Signaling functions of Peli family of E3 ubiquitin ligases
E3 泛素连接酶 Peli 家族的信号传导功能
- 批准号:
9044725 - 财政年份:2013
- 资助金额:
$ 48.88万 - 项目类别:
Signaling functions of Peli family of E3 ubiquitin ligases
E3 泛素连接酶 Peli 家族的信号传导功能
- 批准号:
8469642 - 财政年份:2013
- 资助金额:
$ 48.88万 - 项目类别:
Molecular Mechanisms Regulating Noncanonical NF-kB Signaling
调节非典型 NF-kB 信号传导的分子机制
- 批准号:
7807470 - 财政年份:2009
- 资助金额:
$ 48.88万 - 项目类别:
Signaling Functions of the Tumor Suppressor CYLD
肿瘤抑制因子 CYLD 的信号传导功能
- 批准号:
7150300 - 财政年份:2006
- 资助金额:
$ 48.88万 - 项目类别:
Signaling Functions of the Tumor Suppressor CYLD
肿瘤抑制因子 CYLD 的信号传导功能
- 批准号:
7247127 - 财政年份:2006
- 资助金额:
$ 48.88万 - 项目类别:
Regulation of T-cell function and autoimmune inflammation by deubiquitinase CYLD
去泛素酶 CYLD 对 T 细胞功能和自身免疫炎症的调节
- 批准号:
8046495 - 财政年份:2006
- 资助金额:
$ 48.88万 - 项目类别:
Signaling Functions of the Tumor Suppressor CYLD
肿瘤抑制因子 CYLD 的信号传导功能
- 批准号:
7493501 - 财政年份:2006
- 资助金额:
$ 48.88万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 48.88万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 48.88万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 48.88万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 48.88万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 48.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 48.88万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 48.88万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 48.88万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 48.88万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 48.88万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




